Experimental cancer treatment tested in terminated early trial
NCT ID NCT05159050
Summary
This early-stage trial tested a new way to deliver chemotherapy directly into the abdomen for patients with advanced cancer that had spread throughout the abdominal cavity. The study involved placing tiny drug-loaded particles into the abdomen to target tumors more directly. Only 4 patients were enrolled before the trial was terminated, with researchers primarily looking to determine safe dosage levels and monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL CARCINOMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.